HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tanja N Fehm Selected Research

G-Protein-Coupled Receptors (Receptors, G Protein Coupled)

1/2017Prominent Oncogenic Roles of EVI1 in Breast Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tanja N Fehm Research Topics

Disease

52Breast Neoplasms (Breast Cancer)
02/2024 - 12/2011
12Neoplasms (Cancer)
06/2022 - 06/2012
7Triple Negative Breast Neoplasms
01/2023 - 06/2012
4Endometriosis
03/2022 - 06/2017
4Neoplasm Metastasis (Metastasis)
12/2020 - 12/2011
2Brain Neoplasms (Brain Tumor)
06/2022 - 12/2018
2Circulating Neoplastic Cells
01/2022 - 01/2017
2Ovarian Neoplasms (Ovarian Cancer)
12/2019 - 03/2018
1Residual Neoplasm
09/2022
1Infertility (Sterility)
03/2022
1Leukopenia
01/2022
1Pathologic Complete Response
05/2021
1Metrorrhagia (Spotting)
01/2021
1Endometritis
12/2020
1Vomiting
03/2018
1Nausea
03/2018
1Alopecia (Baldness)
03/2018
1Spontaneous Abortion (Miscarriage)
06/2017
1Cardiotoxicity
01/2017

Drug/Important Bio-Agent (IBA)

17Hormones (Hormone)IBA
06/2023 - 06/2012
8Biomarkers (Surrogate Marker)IBA
01/2023 - 03/2018
6Poly(ADP-ribose) Polymerase InhibitorsIBA
06/2022 - 03/2018
5pertuzumabIBA
06/2021 - 01/2019
4Immune Checkpoint InhibitorsIBA
06/2022 - 04/2020
3pembrolizumabIBA
03/2023 - 09/2022
3Progesterone Receptors (Progesterone Receptor)IBA
03/2022 - 04/2020
2Letrozole (Femara)FDA LinkGeneric
02/2024 - 02/2024
2abemaciclibIBA
06/2023 - 03/2023
2olaparibIBA
06/2023 - 03/2023
2atezolizumabIBA
03/2023 - 12/2019
2Immunoconjugates (Immunoconjugate)IBA
03/2023 - 05/2021
2sacituzumab govitecanIBA
03/2023 - 06/2022
2trastuzumab deruxtecanIBA
09/2022 - 06/2022
2Estrogen ReceptorsIBA
03/2022 - 01/2017
2LigandsIBA
03/2022 - 06/2012
2Phenobarbital (Luminal)FDA Link
01/2022 - 04/2021
2AnthracyclinesIBA
10/2020 - 01/2017
2Ado-Trastuzumab EmtansineIBA
10/2020 - 10/2019
1Aromatase InhibitorsIBA
02/2024
1Local AnestheticsIBA
03/2023
1130-nm albumin-bound paclitaxelIBA
01/2023
1AlpelisibIBA
06/2022
1tucatinibIBA
06/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2022
1Syndecan-1 (Syndecan 1)IBA
03/2022
1CXC ChemokinesIBA
03/2022
1talazoparibIBA
02/2022
1giredestrantIBA
02/2022
1Complement System Proteins (Complement)IBA
01/2022
1Circulating Tumor DNAIBA
01/2022
1neratinibIBA
06/2021
1Capecitabine (Xeloda)FDA Link
06/2021
1Cyclin-Dependent Kinase 4IBA
05/2021
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
01/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1Doxycycline (Periostat)FDA LinkGeneric
12/2020
1seribantumabIBA
11/2020
1histidine-rich proteinsIBA
11/2020
1Taxoids (Taxanes)IBA
10/2020
1GemcitabineFDA Link
10/2020
1Trastuzumab (Herceptin)FDA Link
01/2019
1human ERBB2 proteinIBA
12/2018
1Testosterone (Sustanon)FDA Link
06/2017
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2017
1Estrogens (Estrogen)FDA Link
01/2017
1ErbB Receptors (EGF Receptor)IBA
06/2012
1Proteins (Proteins, Gene)FDA Link
06/2012
1CeramidesIBA
06/2012
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
12/2011

Therapy/Procedure

35Therapeutics
02/2024 - 06/2012
10Drug Therapy (Chemotherapy)
01/2023 - 01/2017
7Neoadjuvant Therapy
03/2023 - 01/2019
2Radiotherapy
02/2023 - 01/2023
2Adjuvant Chemotherapy
10/2020 - 01/2017
2Immunotherapy
12/2019 - 10/2019
2Precision Medicine
11/2018 - 11/2018
1Combination Drug Therapy (Combination Chemotherapy)
12/2019